Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review.
Airoldi M, Amadori D, Barni S, Cinieri S, De Placido S, Di Leo A, Gennari A, Iacobelli S, Ionta MT, Lorusso V, Lotrionte M, Marchetti P, Mattioli R, Minotti G, Pronzato P, Rosti G, Tondini CA, Veronesi A.
Airoldi M, et al. Among authors: veronesi a.
Tumori. 2011 Nov-Dec;97(6):690-2. doi: 10.1177/030089161109700602.
Tumori. 2011.
PMID: 22322832
Review.